4Yarnell JWG, Baker IA, Sweetnam PM, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease,Tcaerphilly and speed well collaborative heart daiseases studies [J].Circulation, 1991:83:836
5Koh KK, Horne 111 MK, Cannon 111 RO. Effects of hormone replace ment therapy on coagulation, fibrinolysis, and thrombosis risk in post menopausal women [J]. Thrombosis and Haemostasis, 1999,82:626
6Stolpe A, Jacobs N, Haje WJ,et al. Fibrnogen binding to ICAM-1 to EA. hy 926 endthelial cell is dependent on an in tact cytoske leton,Thromb [J]. Thromb Hacmost, 1996,75:182
7Kannel WB,Agostino RB,Wilson PWF,et al. Diabetes,fibriongen and risk of cardiovascular disease:the Framingham experrence [J]. Am Heart J,1990,120(3) :672
8Erlich JH,Holdsworth SR,Tipping PG.Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class Ⅱ expression in crescentic glomerulonephritis[J].Am J Pathol,1997,150 (3):873-880.
9Hamano K,Iwano M,Akai Y,et al.Expression of glomenrular plasminogen activator type Ⅰ in glomerulonephritis[J].Am J Kindey Dis,2002,39 (4):695-705.
